QT
VKTX icon

Quantbot Technologies’s Viking Therapeutics VKTX Stock Holding History

Quantbot Technologies’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+2,848
New +$92K ﹤0.01% 1439
2026
Q1 		– Sell
-2,159
Closed -$76K – 2190
2025
Q4 		$76K Sell
2,159
-6,582
-75% -$233K ﹤0.01% 1468
2025
Q3 		$230K Buy
+8,741
New +$261K 0.01% 1251
2024
Q3 		– Sell
-5,388
Closed -$286K – 1863
2024
Q2 		$286K Buy
5,388
+5,014
+1,341% +$329K 0.01% 887
2024
Q1 		$30.7K Buy
+374
New +$16.6K ﹤0.01% 1382
2021
Q4 		– Sell
-200
Closed -$1K – 1950
2021
Q3 		$1K Buy
+200
New +$1.24K ﹤0.01% 1458
2020
Q1 		– Sell
-200
Closed -$1K – 1416
2019
Q4 		$1K Buy
+200
New +$1.46K ﹤0.01% 1161
2018
Q4 		– Sell
-6,284
Closed -$109K – 1440
2018
Q3 		$109K Buy
+6,284
New +$74.8K 0.01% 860

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quantbot Technologies's VKTX Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 2,848 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in VKTX as recently as Q4 2025.

Quantbot Technologies first reported a position in VKTX in Q3 2018 and has held it in 8 quarters since. The position peaked at $286K in Q2 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quantbot Technologies held 2,848 shares of Viking Therapeutics worth $111K as of Q2 2026.
  • Viking Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1439 holding.
  • Quantbot Technologies first reported a position in Viking Therapeutics in Q3 2018 and has held it in 8 quarters since.
  • Quantbot Technologies's Viking Therapeutics position peaked at $286K in Q2 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.